SOLD OUT – Please contact Nicole Pitcher (0409 182 900) with any enquiries.

Manufacturing, Markets & Minefields

Medical technology and the development of new devices and diagnostics co-exist in a dynamic landscape in 2020. Industry 4.0, the fourth industrial revolution, is connecting the physical and digital worlds in ways never witnessed before. But questions remain – what are the opportunities and benefits of this revolution? And what impact will Industry 4.0 have on Victorian medical technologies?

BioMelbourne Network’s 8th Annual Devices + Diagnostics Lab will explore the theme “Manufacturing, Markets and Minefields” within the medical technology and healthcare markets. This must-attend one-day symposium will deliver thought-provoking discussions from industry experts, and allow opportunities to create productive partnerships in an environment designed for sharing knowledge and expertise. Our stellar lineup of keynote speakers, international guests and expert panellists will share their experiences in and knowledge of the sector, and discuss challenges faced by innovators who are marketing Victorian grown medical devices.

If you are active in the industry, have an innovative idea, a device in development or a product ready for market, attending our Devices + Diagnostics Lab is a must!  This event is also recommended for those engaged in commercialisation of medical technologies, exploring opportunities for product development overseas, or designers and developers contemplating their manufacturing strategy.

Be sure to join the discussion on Thursday 5^th March!

When: Thursday 5th March 2020
Schedule: Registration and pre-event networking from 8.30am. Official event opening at 8.45am. Program sessions 9.00am – 5.00pm, followed by networking drinks until 6.30pm.
Where: Theatrette, International Chamber House, Level 5, 121 Exhibition Street, Melbourne
Price (includes GST):
$295 – Members
$550 – Non Members
To check if your organisation is a member click here.
Cancellation Policy: A full refund is given up to 14 days prior to the event. No refunds within 14 days of the event

Who Should Attend
Business leaders, entrepreneurs, investors, product developers, clinicians, researchers, and industry experts across medical technology, ICT, engineering, design, manufacturing and health innovation.

For the agenda and speaker bios please click here to be directed to an event specific website.

Program

Session 1
MANUFACTURING LANDSCAPE
What is Industry 4.0 and what does it mean for medtech? We set the scene by explaining Industry 4.0 and outlining Victoria’s medtech industry landscape.  Some of the key challenges will be discussed and practical opportunities presented.

• Sharon Rice, Executive Director, Major Projects, Pathways and Vocational Education, Swinburne University of Technology
• Dr Jason Coonan, Chief Operating Officer, Innovative Manufacturing CRC (IMCRC)
• Dr Sean Gallagher, Director – Centre for the New Workforce, Swinburne University of Technology

Session 2
MARKETS
Key to the success of any product is knowing and serving the market. In this session you will learn about driving innovation and the capabilities needed in a good manufacturer. Our speakers will also talk about how to ensure your product is viable and what are the factors that can affect its viability or that can affect its acceptance in the marketplace.

• Shay Chalmers, Director, Strategic Engineering Australia
• Paul Brennan, Chief Executive Officer, PolyNovo Ltd
• John Sharman, Chief Executive Officer, Medical Developments International
• Dr Ewa Douroux, Marketing Director Asia Pacific, Leica Biosystems
• Session Chair: Stephen Goodall, Commercialisation Adviser, Accelerating Commercialisation, DIIST

Session 3
MINEFIELDS
Medtech manufacturing is challenging. Potential obstacles include regulation, funding issues, the impact of emerging technologies and changing market conditions. This session will see healthcare and biotech manufacturing companies reveal how they identify challenges and successfully incorporate technology and market trends. We will also touch on cyber and manufacturing security and hear from those who encountered challenges along the way. How did they deal with them and what happened next?

• David James, Chief Executive Officer, Scinogy
• Stuart Elliot, Co-Chief Executive Officer and Co-Founder, Planet Innovation
• Vanja Joannidis, Senior Manager, Cyber Security, EY
• Dr Helmut Thissen, Team Leader, Biomaterial Interface Chemistry | Director, Biomedical Materials Translational Facility
  CSIRO Manufacturing
• Session Chair: Prof. Sally McArthur, Regional Director, Victoria, Medical Device Partnering Program (MDPP)

Plenary Session
MAKING SENSE OF MANUFACTURING, MARKETS & MINEFIELDS
How can we make sense of manufacturing, markets and minefields? As our experts will have explained, it is possible with the right attitude, product and tools. This session looks at how we can grow and develop healthcare and medtech manufacturing in Victoria as a whole. The panel will discuss the role that people can play in our sector to work with the government in supporting, building capability and sustaining the industry in order to respond to industry challenges.

• Hon. Trish White, Board Director, Engineers Australia
• Dr Dan Grant, Managing Director & Chief Executive Officer, MTPConnect
• Biju Kishor, Sales & Marketing Manager, SeerPharma
• Dr Megan Robertson, Director of Research, St Vincent’s Hospital Melbourne
• Sam Vial, Director, Business Development, Sales & Engineering, Motherson Innovations

Session 5
Networking